geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer


, : Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313(13): 1347-1361

Limited information about the relationship between specific mutations in BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists. To identify mutation-specific cancer risks for carriers of BRCA1/2. Observational study of women who were ascertained between 1937 and 2011 (median, 1999) and found to carry disease-associated BRCA1 or BRCA2 mutations. The international sample comprised 19,581 carriers of BRCA1 mutations and 11,900 carriers of BRCA2 mutations from 55 centers in 33 countries on 6 continents. We estimated hazard ratios for breast and ovarian cancer based on mutation type, function, and nucleotide position. We also estimated RHR, the ratio of breast vs ovarian cancer hazard ratios. A value of RHR greater than 1 indicated elevated breast cancer risk; a value of RHR less than 1 indicated elevated ovarian cancer risk. Mutations of BRCA1 or BRCA2. Breast and ovarian cancer risks. Among BRCA1 mutation carriers, 9052 women (46%) were diagnosed with breast cancer, 2317 (12%) with ovarian cancer, 1041 (5%) with breast and ovarian cancer, and 7171 (37%) without cancer. Among BRCA2 mutation carriers, 6180 women (52%) were diagnosed with breast cancer, 682 (6%) with ovarian cancer, 272 (2%) with breast and ovarian cancer, and 4766 (40%) without cancer. In BRCA1, we identified 3 breast cancer cluster regions (BCCRs) located at c.179 to c.505 (BCCR1; RHR = 1.46; 95% CI, 1.22-1.74; P = 2 × 10(-6)), c.4328 to c.4945 (BCCR2; RHR = 1.34; 95% CI, 1.01-1.78; P = .04), and c. 5261 to c.5563 (BCCR2', RHR = 1.38; 95% CI, 1.22-1.55; P = 6 × 10(-9)). We also identified an ovarian cancer cluster region (OCCR) from c.1380 to c.4062 (approximately exon 11) with RHR = 0.62 (95% CI, 0.56-0.70; P = 9 × 10(-17)). In BRCA2, we observed multiple BCCRs spanning c.1 to c.596 (BCCR1; RHR = 1.71; 95% CI, 1.06-2.78; P = .03), c.772 to c.1806 (BCCR1'; RHR = 1.63; 95% CI, 1.10-2.40; P = .01), and c.7394 to c.8904 (BCCR2; RHR = 2.31; 95% CI, 1.69-3.16; P = .00002). We also identified 3 OCCRs: the first (OCCR1) spanned c.3249 to c.5681 that was adjacent to c.5946delT (6174delT; RHR = 0.51; 95% CI, 0.44-0.60; P = 6 × 10(-17)). The second OCCR spanned c.6645 to c.7471 (OCCR2; RHR = 0.57; 95% CI, 0.41-0.80; P = .001). Mutations conferring nonsense-mediated decay were associated with differential breast or ovarian cancer risks and an earlier age of breast cancer diagnosis for both BRCA1 and BRCA2 mutation carriers. Breast and ovarian cancer risks varied by type and location of BRCA1/2 mutations. With appropriate validation, these data may have implications for risk assessment and cancer prevention decision making for carriers of BRCA1 and BRCA2 mutations.

US$19.90

PMID: 25849179

DOI: 10.1001/jama.2014.5985


Other references

Akiyama, H.; Kondo, H.; Ikeda, K.; Kato, M.; McGeer, P.L., 2001: Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. We investigated the immunohistochemical localization of neprilysin, a putative amyloid beta-protein (Abeta)-degrading enzyme, in postmortem human brain tissues. In the cerebral cortex, neprilysin immunoreactivity was weak, but relatively dense dis...

Lee, S-Wha.; Yoo, J.; Lee, S-Hyoung.; Kim, D.; Kim, Y-Man.; Kim, Y-Tak., 2014: Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells. The reciprocal regulation of c-Src and STAT3 activation seems to be associated with the poor response to c-Src inhibitors of ovarian cancer. This study aims to investigate inhibition of cell proliferation and enhancement of the cytotoxic effect of...

Carta, M.Giovanni.; Zairo, F.; Mellino, G.; Hardoy, M.Carolina.; Vieta, E., 2006: An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients. Atypical antipsychotics are widely used in the treatment of bipolar disorders. Amisulpride is an atypical antipsychotic that has been proven to be effective in treatment of schizophrenia, major depressive disorder and, more recently, acute mania....

Motenko, R.G.; Kuznetsova, Y.P., 2011: Effect of ground ice and pore water in volcanic ashes on their thermal conductivity Kamchatka. Ice and Snow 2.114: 99-104

Bhat, O.; Koul, V.K.; Masoodi, K.; Bhagat, K.; Bhan, R., 2005: Seasonal phonology and management of apple blossom thrips in Kashmir. Species composition of thrips infesting apple blossom in Kashmir, revealed the presence of Thrips carthemi Shumsher and Haplothrips. Thrips carthemi Shumsher was more prominant than Haplothrips sp. infesting apple blossom. Amongst the sample techn...

Brook A.J., 1992: Taxonomic revisions to a very polymorphic group the desmidiaceae problems and attitudes. British Phycological Journal 27(1): 85

Wilson, B.; Harwood, L.; Oudshoorn, A.; Thompson, B., 2010: The culture of vascular access cannulation among nurses in a chronic hemodialysis unit. The native arteriovenous fistula (AVF) is the vascular access of choice for patients on chronic hemodialysis (HD) because of its longevity and lower complication rate. Yet from 2001 to 2004 in Canada, there has been a notable increase in both inci...

Kelly, M.D., 2007: Dysphagia lusoria. Anz Journal of Surgery 77(11): 1025-1025

Zellweger, H., 1965: Mongolism--Down's syndrome. Ergebnisse der Inneren Medizin und Kinderheilkunde 22: 268-363

Serikawa, Shin, 1994: Studies on the protection against Corynebacterium pseudotuberculosis infection in sheep. Report of Hokkaido Prefectural Agricultural Experiment Stations 0(84): 1-17